Clinical Trial

Impact of FDG-PET/CT on Management of Patients with Native Valve Infective Endocarditis

Study acronym: PET-NAVIE
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated November 22, 2024 (before its estimated December 31, 2025 completion). Its status may not reflect the trial's current state.
Summary
The proposed study is a multicentric prospective observational cohort study of patients with suspected NVE. The study population includes those with Possible IE according to the modified Duke criteria and investigated at one of the 6 participating sites which include 2 cardiac centers, the MHI and the IUCPQ, as well as 4 tertiary care centers, the Jewish General Hospital , the McGill University Health Centre and the CHUS.
Protocol Amendment History 4 amendments
This ClinicalTrials.gov record has been amended 4 times since 2021-03-09; most recent amendment 2024-11-19.
Status change: Not Yet Recruiting → Recruiting 2021-03-26
Trial Details
NCT Number NCT04792281
Lead Sponsor Montreal Heart Institute
Conditions Infective Endocarditis, Native Valve Endocarditis
Enrollment 97 participants
Start Date 2021-08-31
Primary Completion 2025-12-31 (estimated)
Study Completion 2025-12-31 (estimated)
Updated on ClinicalTrials.gov 2024-11-22